Literature DB >> 26983951

Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014.

Yea-Hung Chen1, Jonathan M Snowden2, Willi McFarland1,3, H Fisher Raymond4,5.   

Abstract

The Food and Drug Administration approved pre-exposure prophylaxis (PrEP) to prevent HIV infection, and the Centers for Disease Control and Prevention has presented PrEP as a prevention option for groups at high risk such as men who have sex with men (MSM). Intervention data provide some information on how PrEP affects sexual behavior of MSM in trials, open label extensions, or clinics. However, it is unclear whether sexual risk and preventive behavioral patterns are changing in the population as a whole as PrEP becomes more widely available, whether due to PrEP use or other factors. We examined trends in PrEP use, numbers of condomless anal sex partners, consistent condom use, and seroadaptive strategies in San Francisco-a city which has actively promoted PrEP-using data from National HIV Behavioral Surveillance (NHBS). NHBS recruited 1211, 383, 373, and 268 HIV-negative MSM in 2004, 2008, 2011, and 2014, respectively. PrEP use increased from zero in 2004, 2008, and 2011 to 9.6 % in 2014. The proportion of men with no condomless anal sex partners dropped from 60.6 % in 2004, to 58.2 % in 2008, to 54.2 % in 2011, to 40.2 % in 2014. Consistent condom use decreased from 36.8 % in 2004, and 30.5 % in 2008 and 2011, to 18.3 % in 2014. PrEP's introduction and scale-up enters in a pre-existing trend of decreasing condom use and increasing sexually transmitted infections among MSM which may be accelerating in recent years. While PrEP use should be scaled up as a prevention option among those who would benefit most, we believe that public health officials need to be realistic about the possibility that condom use could very well continue to decline as PrEP use increases, and to an extent that may not be directly or indirectly offset by PrEP.

Entities:  

Keywords:  MSM; PrEP; Pre-exposure prophylaxis; Seroadaptation

Mesh:

Year:  2016        PMID: 26983951     DOI: 10.1007/s10461-016-1357-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  27 in total

1.  Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.

Authors:  Maximo R Prescott; Jaclyn Hern; Maya Petersen; Glenn-Milo Santos
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

2.  A Latent Class Analysis of Seroadaptation Among Gay and Bisexual Men.

Authors:  Kiffer G Card; Nathan J Lachowsky; Zishan Cui; Allison Carter; Heather Armstrong; Susan Shurgold; David Moore; Robert S Hogg; Eric A Roth
Journal:  Arch Sex Behav       Date:  2016-12-16

3.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

4.  Individual Versus Community-Level Risk Compensation Following Preexposure Prophylaxis of HIV.

Authors:  Martin Holt; Dean A Murphy
Journal:  Am J Public Health       Date:  2017-08-17       Impact factor: 9.308

5.  Distribution of Behavioral Patterns Before Infection Among San Francisco Men Who Have Sex With Men Newly Infected With HIV in 2014.

Authors:  Yea-Hung Chen; Willi McFarland; Henry F Raymond; Hyman M Scott; Eric Vittinghoff; Travis C Porco
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

6.  Estimated Coverage to Address Financial Barriers to HIV Preexposure Prophylaxis Among Persons With Indications for Its Use, United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Rebecca Huggins
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

7.  Historical and Current Trends in the Epidemiology of Early Syphilis in San Francisco, 1955 to 2016.

Authors:  Trang Quyen Nguyen; Robert P Kohn; Rilene Chew Ng; Susan S Philip; Stephanie E Cohen
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

8.  Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance.

Authors:  Mingwang Shen; Yanni Xiao; Libin Rong; Lauren Ancel Meyers; Steven E Bellan
Journal:  Proc Biol Sci       Date:  2017-06-28       Impact factor: 5.349

Review 9.  Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men.

Authors:  Chelsea P Roberts; Jeffrey D Klausner
Journal:  Expert Rev Anti Infect Ther       Date:  2016-09-23       Impact factor: 5.091

Review 10.  Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.

Authors:  Elske Hoornenborg; Douglas S Krakower; Maria Prins; Kenneth H Mayer
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.